Literature DB >> 7738609

A phase I trial on the ethics of phase I trials.

E J Emanuel.   

Abstract

Keywords:  Biomedical and Behavioral Research; Empirical Approach

Mesh：

Substances：

Year:  1995        PMID： 7738609     DOI： 10.1200/JCO.1995.13.5.1049

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  7 in total

1.  Communicating about phase I trials: objective disclosures are only a first step.

Authors:  Anne Lederman Flamm; Rebecca D Pentz
Journal:  Oncologist       Date:  2012-04-04

2.  Prognostic factors among cancer patients with good performance status screened for phase I trials.

Authors:  Nicolas Penel; Marie Vanseymortier; Marie-Edith Bonneterre; Stéphanie Clisant; Eric Dansin; Yvette Vendel; Régis Beuscart; Jacques Bonneterre
Journal:  Invest New Drugs       Date:  2007-09-22       Impact factor: 3.850

3.  Quality assessment of phase I dose-finding cancer trials: proposal of a checklist.

Authors:  Sarah Zohar; Qing Lian; Vincent Levy; Ken Cheung; Anastasia Ivanova; Sylvie Chevret
Journal:  Clin Trials       Date:  2008       Impact factor: 2.486

4.  Therapeutic misconception, misestimation, and optimism in participants enrolled in phase 1 trials.

Authors:  Rebecca D Pentz; Margaret White; R Donald Harvey; Zachary Luke Farmer; Yuan Liu; Colleen Lewis; Olga Dashevskaya; Taofeek Owonikoko; Fadlo R Khuri
Journal:  Cancer       Date:  2012-01-31       Impact factor: 6.860

5.  Development and validation of a model that predicts early death among cancer patients participating in phase I clinical trials investigating cytotoxics.

Authors:  Nicolas Penel; Jean-Pierre Delord; Marie-Edith Bonneterre; Thomas Bachelot; Isabelle Ray-Coquard; Jean-Yves Blay; Laurent Benjamin Pascal; Cécile Borel; Thomas Filleron; Antoine Adenis; Jacques Bonneterre
Journal:  Invest New Drugs       Date:  2009-02-10       Impact factor: 3.850

6.  The impact of an educational DVD on cancer patients considering participation in a phase I clinical trial.

Authors:  Elizabeth L Strevel; Colin Newman; Gregory R Pond; Martha MacLean; Lillian L Siu
Journal:  Support Care Cancer       Date:  2007-07       Impact factor: 3.359

7.  Prediction of early death among patients enrolled in phase I trials: development and validation of a new model based on platelet count and albumin.

Authors:  A Ploquin; D Olmos; D Lacombe; R A'Hern; A Duhamel; C Twelves; S Marsoni; R Morales-Barrera; J-C Soria; J Verweij; E E Voest; P Schöffski; J H Schellens; A Kramar; R S Kristeleit; H-T Arkenau; S B Kaye; N Penel
Journal:  Br J Cancer       Date:  2012-08-21       Impact factor: 7.640
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.